After hitting record high after record high in 2025, the S&P 500 looks very pricey indeed. However, there are still pockets of value lurking in this index.

Synthomer has collapsed into penny stock territory despite £2bn in annual revenue. Mark Hartley explores whether a recovery is possible. When investing, your capital is at risk. The value of your ...

With the US stock market at record highs and with investors so complacent, this Fool explains why he is not buying the rosy narrative.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in. The content of this article is provided for information ...

Phoenix Group Holdings PLC is a British closed life assurance fund consolidator. Its main specialisation is the management and acquisition of closed life and pension funds. It operates mainly in the ...

DCC PLC is an international sales, marketing, and support services company operating across four divisions: LPG, Retail and Oil, Technology, and Healthcare. The company's trading activities are ...

See the most recent Reach plc (LSE:RCH) share price, news, company analysis, and price history from our financial experts.

Admiral was launched in 1993 as a division of Brockbank. In 1999, it was bought in a management buyout backed by Barclays Private Equity. The group specialises in providing low cost car insurance for ...

Celebrus Technologies Plc engages in the provision of data solutions through its Celebrus suite of products and services. The company's product suite Celebrus CDP captures, contextualizes, and ...

After falling 95% in the last four years, is this hydrogen business on the verge of an explosive comeback? Here are the latest analyst forecasts. The content of this article was relevant at the time ...

After a minor tariff-induced hiccup, the S&P 500 looks primed to continue last year’s stellar rally. Mark Hartley considers one AI stock driving growth. The content of this article was relevant at the ...

Lloyds shares appear to be plateauing after surging beyond market expectations over the past year. Dr James Fox takes a closer look. The content of this article was relevant at the time of publishing.